文献速递先天性心脏病外科

澳大利亚和新西兰Fontan拆除术后远期结局

Long-term outcomes following Fontan takedown in Australia and New Zealand.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-10-06

该研究基于澳大利亚和新西兰Fontan登记处,评估Fontan拆除术后的早期和晚期结局。在1975至2018年间,1540例患者中36例(2.3%)行Fontan拆除,中位拆除年龄5.1岁,16例(44%)死亡,拆除后1、5、10年免于死亡/移植分别为59%、56%、52%。

要点

  • Fontan拆除发生率低(2.3%),但死亡率高(44%)。
  • 拆除时机与死亡率相关,3周至6个月间拆除死亡率最高(79%)。
  • 少数存活者可再次行Fontan(14%)。

核心结论

  • Fontan拆除发生率低但死亡率高,多数拆除发生在6个月内,拆除时机与死亡率相关。

研究设计与样本

  • 回顾性登记处研究,检索澳大利亚和新西兰Fontan登记处1975至2018年共43年数据,纳入36例行Fontan拆除的患者。

主要发现

  • 36/1540(2.3%)行Fontan拆除,中位拆除年龄5.1岁(IQR 3.7,7.0),中位拆除间隔26天(IQR 1.5,127.5)。
  • 16例(44%)死亡,中位死亡时间57.5天(IQR 21.8,76.8)。
  • 中位随访9.4年(IQR 4.5,15.3),11例(31%)存活于中间循环,其中10例NYHA I/II级;5例(14%)成功行第二次Fontan。
  • 拆除后1、5、10年免于死亡/移植分别为59%、56%、52%。

临床怎么用

  • Fontan失败需拆除时应认识其高死亡风险,拆除时机可能影响预后,3周至6个月间拆除死亡率最高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fontan takedown remains an option for the management of Fontan failure. We sought to evaluate early and late outcomes after Fontan takedown. METHODS: The Australia and New Zealand Fontan Registry was interrogated to identify all patients who had a Fontan takedown. RESULTS: Over a 43-year study period (1975-2018), 36 of 1540 (2.3%) had a Fontan takedown. The median age at takedown was 5.1 years (interquartile range [IQR], 3.7, 7.0). Nine (25%) patients had a takedown within 48 hours, 6 (16%) between 2 days and 3 weeks, 14 (39%) between 3 weeks and 6 months, whereas 7 (19%) had a late takedown (>6 months). Median interval to takedown was 26 days (IQR, 1.5, 127.5). Sixteen (44%) patients died at a median of 57.5 days (IQR, 21.8, 76.8). The greatest mortality occurred between 3 weeks and 6 months (<2 days: 1/9, 11%; 2 days to 3 weeks: 2/6, 33%; 3 weeks to 6 months: 11/14, 79%; >6 months: 2/7, 28%; P = .007). At median follow-up of 9.4 years (IQR, 4.5, 15.3), 11 (31%) patients were alive with an intermediate circulation (10 in New York Heart Association class I/II). Five (14%) patients underwent a successful second Fontan. Freedom from death/transplant after Fontan takedown was 59%, 56%, and 52% at 1, 5, and 10 years, respectively. CONCLUSIONS: The incidence of Fontan takedown is low, but mortality is high. The majority of takedowns occurred within 6 months. Mortality was lowest when takedown occurred <2 days and highest between 3 weeks and 6 months. A second Fontan is possible in a small proportion of survivors.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Marathe SP, Iyengar AJ, Betts KS, et al. Long-term outcomes following Fontan takedown in Australia and New Zealand. J Thorac Cardiovasc Surg. 2020. PMID: 33131894. doi:10.1016/j.jtcvs.2020.09.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。